首页 > 最新文献

Journal of the Royal Society of Medicine最新文献

英文 中文
Reporting and representation of underserved groups in intervention studies for patients with multiple long-term conditions: a systematic review 针对多种长期病症患者的干预研究中服务不足群体的报告和代表性:系统综述
IF 17.3 2区 医学 Q1 Medicine Pub Date : 2024-04-16 DOI: 10.1177/01410768241233109
Zara Kayani, Andrew Willis, Shukrat O Salisu-Olatunji, Shavez Jeffers, Kamlesh Khunti, Ash Routen
ObjectivesGlobally, there is a growing number of people who are living with multiple long-term conditions (MLTCs). Due to complex management needs, it is imperative that research consists of participants who may benefit most from interventions. It is well documented that ethnic minority groups and lower socioeconomic status (SES) groups are at an increased risk of developing MLTCs. Therefore, the aim of this systematic review was to determine the level of reporting and representation of underserved groups (ethnic minority and low SES) in intervention studies addressing MLTCs.DesignSystematic review. Four databases including Cochrane Library, MEDLINE, CINAHL and Scopus were searched for intervention studies from North America or Europe published between January 1990 and July 2023.SettingHospital and community-based interventions. We included interventional studies focusing on improving MLTC-related outcomes.ParticipantsPatients with MLTCs.Main outcome measuresTotal number of studies reporting on ethnicity and SES. Number and proportion of studies reporting by ethnic/SES group.ResultsThirteen studies met the inclusion criteria. Only 4 of 13 studies (31%) recorded and reported ethnicity information. Of these four studies that reported on ethnicity, three studies consisted of primarily White participants. Ethnic minority groups were underrepresented, but one study included a majority of African American participants. Moreover, 12 of 13 studies (92%) reported on SES with income and educational level being the primary measures used. SES representation of higher deprivation groups was varied due to limited data.ConclusionsFor ethnicity, there was a lack of reporting, and ethnic minority groups were underrepresented in intervention studies. For SES, there was a high level of reporting but the proportion of study samples from across the spectrum of SES varied due to the variety of SES measures used. Findings highlight a need to improve the reporting and representation of ethnic minority groups and provide more detailed information for SES through using consistent measures (e.g. education, income and employment) to accurately determine the distribution of SES groups in intervention studies of people with MLTCs.
目标在全球范围内,患有多种长期疾病(MLTCs)的人越来越多。由于复杂的管理需求,研究必须包括可能从干预措施中获益最多的参与者。有资料表明,少数民族群体和社会经济地位(SES)较低的群体罹患多种长期病症的风险更高。因此,本系统性综述旨在确定在针对 MLTCs 的干预研究中,未得到充分服务的群体(少数民族和社会经济地位较低)的报告水平和代表性。我们在 Cochrane Library、MEDLINE、CINAHL 和 Scopus 等四个数据库中检索了 1990 年 1 月至 2023 年 7 月间发表的北美或欧洲干预研究。主要结果测量报告种族和社会经济地位的研究总数。结果13项研究符合纳入标准。13 项研究中只有 4 项(31%)记录并报告了种族信息。在这四项报告了种族信息的研究中,有三项研究的参与者主要是白人。少数族裔群体所占比例较低,但有一项研究的大多数参与者为非洲裔美国人。此外,13 项研究中有 12 项(92%)报告了社会经济地位,其中收入和教育水平是主要的衡量标准。结论 在种族方面,缺乏报告,少数族裔群体在干预研究中的代表性不足。在社会经济地位方面,报告水平较高,但由于所使用的社会经济地位衡量标准不同,来自不同社会经济地位群体的研究样本比例也各不相同。研究结果突出表明,有必要改进少数族裔群体的报告和代表性,并通过使用一致的测量方法(如教育、收入和就业)来提供更详细的社会经济地位信息,以准确确定多发性骨髓瘤患者干预研究中社会经济地位群体的分布情况。
{"title":"Reporting and representation of underserved groups in intervention studies for patients with multiple long-term conditions: a systematic review","authors":"Zara Kayani, Andrew Willis, Shukrat O Salisu-Olatunji, Shavez Jeffers, Kamlesh Khunti, Ash Routen","doi":"10.1177/01410768241233109","DOIUrl":"https://doi.org/10.1177/01410768241233109","url":null,"abstract":"ObjectivesGlobally, there is a growing number of people who are living with multiple long-term conditions (MLTCs). Due to complex management needs, it is imperative that research consists of participants who may benefit most from interventions. It is well documented that ethnic minority groups and lower socioeconomic status (SES) groups are at an increased risk of developing MLTCs. Therefore, the aim of this systematic review was to determine the level of reporting and representation of underserved groups (ethnic minority and low SES) in intervention studies addressing MLTCs.DesignSystematic review. Four databases including Cochrane Library, MEDLINE, CINAHL and Scopus were searched for intervention studies from North America or Europe published between January 1990 and July 2023.SettingHospital and community-based interventions. We included interventional studies focusing on improving MLTC-related outcomes.ParticipantsPatients with MLTCs.Main outcome measuresTotal number of studies reporting on ethnicity and SES. Number and proportion of studies reporting by ethnic/SES group.ResultsThirteen studies met the inclusion criteria. Only 4 of 13 studies (31%) recorded and reported ethnicity information. Of these four studies that reported on ethnicity, three studies consisted of primarily White participants. Ethnic minority groups were underrepresented, but one study included a majority of African American participants. Moreover, 12 of 13 studies (92%) reported on SES with income and educational level being the primary measures used. SES representation of higher deprivation groups was varied due to limited data.ConclusionsFor ethnicity, there was a lack of reporting, and ethnic minority groups were underrepresented in intervention studies. For SES, there was a high level of reporting but the proportion of study samples from across the spectrum of SES varied due to the variety of SES measures used. Findings highlight a need to improve the reporting and representation of ethnic minority groups and provide more detailed information for SES through using consistent measures (e.g. education, income and employment) to accurately determine the distribution of SES groups in intervention studies of people with MLTCs.","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":null,"pages":null},"PeriodicalIF":17.3,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140611520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adolf Bingel (1879–1953), a member of the last generation of general internal physicians in Germany 阿道夫-宾格尔(1879-1953 年),德国最后一代全科内科医生
IF 17.3 2区 医学 Q1 Medicine Pub Date : 2024-04-03 DOI: 10.1177/01410768241236677
Ulrich Tröhler
{"title":"Adolf Bingel (1879–1953), a member of the last generation of general internal physicians in Germany","authors":"Ulrich Tröhler","doi":"10.1177/01410768241236677","DOIUrl":"https://doi.org/10.1177/01410768241236677","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":null,"pages":null},"PeriodicalIF":17.3,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140578673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Johann Friedrich de Quervain (1868–1940): Swiss surgical innovator 约翰-弗里德里希-德-克尔万(Johann Friedrich de Quervain,1868-1940 年):瑞士外科创新者
IF 17.3 2区 医学 Q1 Medicine Pub Date : 2024-04-03 DOI: 10.1177/01410768241236681
Ulrich Tröhler
{"title":"Johann Friedrich de Quervain (1868–1940): Swiss surgical innovator","authors":"Ulrich Tröhler","doi":"10.1177/01410768241236681","DOIUrl":"https://doi.org/10.1177/01410768241236681","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":null,"pages":null},"PeriodicalIF":17.3,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140602571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
For more events and to book online, please visit www.rsm.ac.uk/events. 如需了解更多活动和在线预订,请访问 www.rsm.ac.uk/events。
IF 17.3 2区 医学 Q1 Medicine Pub Date : 2024-04-01 DOI: 10.1177/01410768241255033
{"title":"For more events and to book online, please visit www.rsm.ac.uk/events.","authors":"","doi":"10.1177/01410768241255033","DOIUrl":"10.1177/01410768241255033","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":null,"pages":null},"PeriodicalIF":17.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100450/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140945409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of a good doctor. 好医生的特点。
IF 17.3 2区 医学 Q1 Medicine Pub Date : 2024-04-01 Epub Date: 2024-03-18 DOI: 10.1177/01410768241230773
Dinesh Bhugra
{"title":"Characteristics of a good doctor.","authors":"Dinesh Bhugra","doi":"10.1177/01410768241230773","DOIUrl":"10.1177/01410768241230773","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":null,"pages":null},"PeriodicalIF":17.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100452/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140143742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study. 英格兰接种第一剂和第二剂新冠肺炎疫苗后的不良事件:国家疫苗监测平台自我控制的病例系列研究。
IF 17.3 2区 医学 Q1 Medicine Pub Date : 2024-04-01 Epub Date: 2023-11-03 DOI: 10.1177/01410768231205430
Ruby Sm Tsang, Utkarsh Agrawal, Mark Joy, Rachel Byford, Chris Robertson, Sneha N Anand, William Hinton, Nikhil Mayor, Debasish Kar, John Williams, William Victor, Ashley Akbari, Declan T Bradley, Siobhan Murphy, Dermot O'Reilly, Rhiannon K Owen, Antony Chuter, Jillian Beggs, Gary Howsam, Aziz Sheikh, F D Richard Hobbs, Simon de Lusignan

Objectives: To estimate the incidence of adverse events of interest (AEIs) after receiving their first and second doses of coronavirus disease 2019 (COVID-19) vaccinations, and to report the safety profile differences between the different COVID-19 vaccines.

Design: We used a self-controlled case series design to estimate the relative incidence (RI) of AEIs reported to the Oxford-Royal College of General Practitioners national sentinel network. We compared the AEIs that occurred seven days before and after receiving the COVID-19 vaccinations to background levels between 1 October 2020 and 12 September 2021.

Setting: England, UK.

Participants: Individuals experiencing AEIs after receiving first and second doses of COVID-19 vaccines.

Main outcome measures: AEIs determined based on events reported in clinical trials and in primary care during post-license surveillance.

Results: A total of 7,952,861 individuals were vaccinated with COVID-19 vaccines within the study period. Among them, 781,200 individuals (9.82%) presented to general practice with 1,482,273 AEIs. Within the first seven days post-vaccination, 4.85% of all the AEIs were reported. There was a 3-7% decrease in the overall RI of AEIs in the seven days after receiving both doses of Pfizer-BioNTech BNT162b2 (RI = 0.93; 95% CI: 0.91-0.94) and 0.96; 95% CI: 0.94-0.98), respectively) and Oxford-AstraZeneca ChAdOx1 (RI = 0.97; 95% CI: 0.95-0.98) for both doses), but a 20% increase after receiving the first dose of Moderna mRNA-1273 (RI = 1.20; 95% CI: 1.00-1.44)).

Conclusions: COVID-19 vaccines are associated with a small decrease in the incidence of medically attended AEIs. Sentinel networks could routinely report common AEI rates, which could contribute to reporting vaccine safety.

目的:估计接种第一剂和第二剂2019冠状病毒病(新冠肺炎)疫苗后感兴趣不良事件(AEI)的发生率,并报告不同新冠肺炎疫苗之间的安全性差异。设计:我们使用自我控制的病例系列设计来估计向牛津皇家全科医生学院国家哨点网络报告的不良事件的相对发生率(RI)。我们将接种新冠肺炎疫苗前后7天发生的不良事件与2020年10月1日至2021年9月12日期间的背景水平进行了比较。背景:英国英格兰。参与者:接种第一剂和第二剂新冠肺炎疫苗后出现不良事件的个人。主要结果指标:根据临床试验和许可证后监测期间初级保健中报告的事件确定AE。结果:在研究期间,共有7952861人接种了新冠肺炎疫苗。其中,781200人(9.82%)接受了全科治疗,共有1482273例不良事件。在接种疫苗后的前7天内,报告了4.85%的不良事件。在接受两剂辉瑞-BioNTech BNT162b2后的七天内,AE的总体RI下降了3-7%(RI = 0.93;95%CI:0.91-0.94)和0.96;95%可信区间:0.94-0.98)和牛津-阿斯利康ChAdOx1(RI = 0.97;95%置信区间:0.95-0.98),但在接受第一剂莫德纳mRNA-1273后增加了20%(RI = 1.20;95%CI:1.00-1.44)。结论:新冠肺炎疫苗与医疗护理不良事件发生率的小幅下降有关。哨兵网络可以定期报告常见的不良事件发生率,这有助于报告疫苗安全性。
{"title":"Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study.","authors":"Ruby Sm Tsang, Utkarsh Agrawal, Mark Joy, Rachel Byford, Chris Robertson, Sneha N Anand, William Hinton, Nikhil Mayor, Debasish Kar, John Williams, William Victor, Ashley Akbari, Declan T Bradley, Siobhan Murphy, Dermot O'Reilly, Rhiannon K Owen, Antony Chuter, Jillian Beggs, Gary Howsam, Aziz Sheikh, F D Richard Hobbs, Simon de Lusignan","doi":"10.1177/01410768231205430","DOIUrl":"10.1177/01410768231205430","url":null,"abstract":"<p><strong>Objectives: </strong>To estimate the incidence of adverse events of interest (AEIs) after receiving their first and second doses of coronavirus disease 2019 (COVID-19) vaccinations, and to report the safety profile differences between the different COVID-19 vaccines.</p><p><strong>Design: </strong>We used a self-controlled case series design to estimate the relative incidence (RI) of AEIs reported to the Oxford-Royal College of General Practitioners national sentinel network. We compared the AEIs that occurred seven days before and after receiving the COVID-19 vaccinations to background levels between 1 October 2020 and 12 September 2021.</p><p><strong>Setting: </strong>England, UK.</p><p><strong>Participants: </strong>Individuals experiencing AEIs after receiving first and second doses of COVID-19 vaccines.</p><p><strong>Main outcome measures: </strong>AEIs determined based on events reported in clinical trials and in primary care during post-license surveillance.</p><p><strong>Results: </strong>A total of 7,952,861 individuals were vaccinated with COVID-19 vaccines within the study period. Among them, 781,200 individuals (9.82%) presented to general practice with 1,482,273 AEIs. Within the first seven days post-vaccination, 4.85% of all the AEIs were reported. There was a 3-7% decrease in the overall RI of AEIs in the seven days after receiving both doses of Pfizer-BioNTech BNT162b2 (RI = 0.93; 95% CI: 0.91-0.94) and 0.96; 95% CI: 0.94-0.98), respectively) and Oxford-AstraZeneca ChAdOx1 (RI = 0.97; 95% CI: 0.95-0.98) for both doses), but a 20% increase after receiving the first dose of Moderna mRNA-1273 (RI = 1.20; 95% CI: 1.00-1.44)).</p><p><strong>Conclusions: </strong>COVID-19 vaccines are associated with a small decrease in the incidence of medically attended AEIs. Sentinel networks could routinely report common AEI rates, which could contribute to reporting vaccine safety.</p>","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":null,"pages":null},"PeriodicalIF":17.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100448/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71424598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why are medicine's leaders missing in action? 为什么医学界的领导者缺席行动?
IF 8.8 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-04-01 DOI: 10.1177/01410768241255015
Kamran Abbasi
{"title":"Why are medicine's leaders missing in action?","authors":"Kamran Abbasi","doi":"10.1177/01410768241255015","DOIUrl":"10.1177/01410768241255015","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":null,"pages":null},"PeriodicalIF":8.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140945411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From JRSM Open 摘自 JRSM Open
IF 17.3 2区 医学 Q1 Medicine Pub Date : 2024-03-13 DOI: 10.1177/01410768241240289
{"title":"From JRSM Open","authors":"","doi":"10.1177/01410768241240289","DOIUrl":"https://doi.org/10.1177/01410768241240289","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":null,"pages":null},"PeriodicalIF":17.3,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140125598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Death Notices 死亡通知
IF 17.3 2区 医学 Q1 Medicine Pub Date : 2024-03-13 DOI: 10.1177/01410768241240291
{"title":"Death Notices","authors":"","doi":"10.1177/01410768241240291","DOIUrl":"https://doi.org/10.1177/01410768241240291","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":null,"pages":null},"PeriodicalIF":17.3,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140125604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are we selecting the right medical students? 我们是否选择了正确的医科学生?
IF 17.3 2区 医学 Q1 Medicine Pub Date : 2024-03-01 Epub Date: 2024-03-25 DOI: 10.1177/01410768241237108
Martin Deahl
{"title":"Are we selecting the right medical students?","authors":"Martin Deahl","doi":"10.1177/01410768241237108","DOIUrl":"10.1177/01410768241237108","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":null,"pages":null},"PeriodicalIF":17.3,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11046367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140288436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Royal Society of Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1